Vimarsana
Biggest News Aggregation in the World

Clinical Isolate News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Isolate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Isolate Today - Breaking & Trending Today

Novel Insights on Lesser Known Food Poisoning Bacteria Could Help Prevention and Treatment - Vimarsana News

Novel Insights on Lesser Known Food Poisoning Bacteria Could Help Prevention and Treatment

Research has revealed the properties of Providencia spp., a type of food poisoning bacteria, and paves way for establishment of preventive methods.<br />

Study provides new insights on bacteria that cause food poisoning - Vimarsana News

Study provides new insights on bacteria that cause food poisoning

Recently, Providencia spp. which have been detected in patients with gastroenteritis, and similar to enterohemorrhagic Escherichia coli. O157 and Salmonella spp., have been attracting attention as causative agents of food poisoning.

Source: phys.org
Clinical staff MRSA carriage and environmenta - Vimarsana News

Clinical staff MRSA carriage and environmenta

Examination tables, scales and other surfaces in small animal veterinary practices are frequently contaminated with multidrug-resistant “superbugs”, the results of a Portuguese study suggest. The research, which is being presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark, (15-18 April) found that 19% of surfaces harboured at least one multidrug-resistant bacterium.

Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that ... - Vimarsana News

Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that ... BioNTech SEJanuary 20, 2021 GMT New York and Mainz, Germany, January 20, 2021 — Today, Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced results from an in vitro study that provides additional data on the capability of sera from individuals immunized with the Pfizer-BioNTech COVID-19 vaccine BNT162b2 to neutralize the SARS-CoV-2 U.K. strain, also known as B.1.1.7 lineage or VOC 202012/...

Source: apnews.com
Investegate |BioNTech SE Announcements | BioNTech SE: Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture - Vimarsana News

Investegate |BioNTech SE Announcements | BioNTech SE: Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture

Investegate announcements from BioNTech SE, Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture